Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Drug Manufacturers - Specialty & Generic
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.


CSE:RVV - Post by User

Revive Therapeutics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(28)
•••
  • cool888X
Post by cool888on Jul 06, 2023 11:02am
252 Views
Post# 35529180

$RVV rethinks plans after seeing scale of C-19 trial fail !

$RVV rethinks plans after seeing scale of C-19 trial fail !#Bucillamine

https://www.fiercebiotech.com/biotech/revive-rethinks-plans-after-seeing-scale-covid-19-trial-fail
 
 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities